1. Home
  2. NAZ vs NERV Comparison

NAZ vs NERV Comparison

Compare NAZ & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Arizona Quality Municipal Income Fund

NAZ

Nuveen Arizona Quality Municipal Income Fund

HOLD

Current Price

$10.51

Market Cap

133.3M

Sector

Finance

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$2.30

Market Cap

166.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAZ
NERV
Founded
1992
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
133.3M
166.4M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
NAZ
NERV
Price
$10.51
$2.30
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $10.33
AVG Volume (30 Days)
60.5K
★ 105.4K
Earning Date
01-01-0001
11-04-2026
Dividend Yield
★ 3.69%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $41,175,600.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.18
$2.24
52 Week High
$13.42
$8.80

Technical Indicators

Market Signals
Indicator
NAZ
NERV
Relative Strength Index (RSI) 31.55 27.35
Support Level $10.18 N/A
Resistance Level $12.62 $5.69
Average True Range (ATR) 0.17 0.26
MACD 0.02 -0.02
Stochastic Oscillator 4.41 4.83

Price Performance

Historical Comparison
NAZ
NERV

About NAZ Nuveen Arizona Quality Municipal Income Fund

Nuveen Arizona Quality Municipal Income Fund is a closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: